INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,888,209 | +743.6% | 438,437 | +776.9% | 0.01% | +550.0% |
| Q3 2022 | $698,000 | -57.1% | 50,000 | -50.0% | 0.00% | -33.3% |
| Q1 2022 | $1,627,000 | -91.9% | 100,000 | -91.9% | 0.00% | -91.7% |
| Q4 2021 | $20,086,000 | -23.8% | 1,233,000 | +124.2% | 0.04% | -46.3% |
| Q2 2020 | $26,351,000 | -0.6% | 550,000 | +65.1% | 0.07% | +1.5% |
| Q2 2019 | $26,505,000 | -53.1% | 333,100 | -34.0% | 0.07% | -53.2% |
| Q1 2019 | $56,489,000 | +306.1% | 505,000 | +265.9% | 0.14% | +261.5% |
| Q4 2018 | $13,909,000 | +8.9% | 138,000 | +79.2% | 0.04% | +11.4% |
| Q3 2015 | $12,771,000 | -39.2% | 77,000 | -11.5% | 0.04% | -32.7% |
| Q2 2015 | $21,000,000 | -33.5% | 87,000 | -22.3% | 0.05% | -32.5% |
| Q1 2015 | $31,579,000 | +68.7% | 111,975 | -6.7% | 0.08% | +67.4% |
| Q4 2014 | $18,720,000 | +92.9% | 120,000 | +192.7% | 0.05% | +91.7% |
| Q3 2014 | $9,704,000 | +173.4% | 41,000 | +173.3% | 0.02% | +166.7% |
| Q2 2014 | $3,549,000 | -80.5% | 15,000 | -72.9% | 0.01% | -82.0% |
| Q1 2014 | $18,226,000 | +52.5% | 55,264 | -68.4% | 0.05% | +56.2% |
| Q4 2013 | $11,949,000 | -57.8% | 175,000 | -57.4% | 0.03% | -60.5% |
| Q3 2013 | $28,348,000 | +44.2% | 410,655 | -6.3% | 0.08% | +32.8% |
| Q2 2013 | $19,659,000 | +82.2% | 438,434 | +52.0% | 0.06% | +69.4% |
| Q1 2013 | $10,787,000 | – | 288,434 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |